Trial Profile
Efficacy of Everolimus for TSC-associated renal angiomyolipoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Angiomyolipoma
- Focus Therapeutic Use
- 16 May 2016 New trial record
- 10 May 2016 Results of preliminary analysis (n=15) presented at the 111th Annual Meeting of the American Urological Association